Genomics Labs · Healthcare Performance Intelligence
Downstream Analytics for Genomics Laboratories
Extend the value of a qualified report into phenotype-aware, longitudinal review while keeping laboratory and clinician responsibilities clear.
Book a DemoBring the data you already collect. Keep the systems that produce it.
The buyer problem
More data has made interpretation harder for genomics laboratory leaders and clinical partnerships teams.
A report is delivered at one point in time. Customers increasingly need structured downstream context, re-review cues and links to changing phenotype without asking the lab to become an EHR.
The answer is not another isolated dashboard. It is a governed way to evaluate change across time and modalities, preserve what each source can and cannot establish, and make the underlying evidence available for review.
Where interpretation breaks
- Reports become static PDFs
- Phenotype updates do not return to the lab
- Evidence dates are hard to track
- Downstream claims exceed report scope
Data landscape
The signals involved
The job is not to force unlike data into one score. It is to preserve provenance, time, context and uncertainty while making the relationships investigable.
Qualified report output
Structured findings, classifications and supporting evidence metadata.
Phenotype supplied by partners
Governed clinical observations relevant to the authorised use.
Longitudinal changes
New diagnoses, biomarkers or therapy context.
Review status
Version, sign-off and unresolved questions.
The intelligence layer
What Vizier adds
Report-to-phenotype context
Connect findings to observed traits without altering lab conclusions.
Re-review cues
Identify materially changed context for qualified reassessment.
Customer intelligence
Show use and follow-up patterns at an appropriate aggregate level.
Traceable boundaries
Keep source interpretation and downstream analysis distinct.
Interpretation discipline
Evidence before certainty
Vizier should make complex data easier to investigate without making the evidence stronger than it is. A temporal relationship is not automatically causal. A genetic association is not a diagnosis. Movement in a surrogate biomarker is not necessarily a clinical outcome.
Findings should retain source, timing, reference context and confidence. Where modalities disagree, data is missing, or follow-up is too short, the useful answer is often that the evidence is insufficient.
The distinctions that matter
- Association is not causality; timing and confounding still matter.
- Genetic predisposition is not the same as expressed phenotype.
- Biomarker movement is not automatically a clinical outcome.
- A biological-age estimate is model output, not a lifespan prediction.
Clear product boundary
What Vizier does—and does not—replace
Vizier does not operate the wet lab, primary bioinformatics, variant calling, classification or signed clinical report.
Vizier consumes authorised outputs from the systems you choose. Source access, format, identity matching, governance, hosting and clinical review responsibilities are confirmed during discovery.
Vizier is not
- A sequencing or FASTQ/BAM/VCF processing pipeline
- A laboratory, EHR, scheduling, billing or CRM system
- A diagnostic device or autonomous clinical decision-maker
- A claim that an intervention caused a later change
Workflow
From fragmented outputs to a reviewable investigation
01
Inventory authorised sources, identifiers, time semantics and decision questions.
02
Validate units, mappings, provenance, missingness and clinically relevant comparison periods.
03
Configure longitudinal and cross-signal investigations around the organisation's reviewed definitions.
04
Return findings with evidence, uncertainty and a traceable path back to source data.
Questions buyers ask
Frequently asked questions
What is genomics labs?
Genomics Labs is the governed analysis of relevant health data for longitudinal and cross-signal questions. For Vizier, that means analysing authorised outputs while retaining provenance, time and uncertainty.
Does Vizier replace our existing clinical or diagnostic systems?
Vizier does not operate the wet lab, primary bioinformatics, variant calling, classification or signed clinical report.
Can Vizier prove that an intervention caused a change?
Not from timing alone. Vizier can align observations to an intervention, show competing explanations and describe the strength of evidence. Causal claims require an appropriate design and expert review.
How does implementation start?
With one decision question and a source inventory. Vizier validates access, identifiers, units, time semantics, governance and the review workflow before a capability is represented as production-ready.
See genomics labs across the data you already collect.
Bring the data you already collect. See what Vizier finds across it.
Start with the data you already have. Connect your EHR when you’re ready.